Null-cell carcinomas of the pituitary are extremely rare. We describe a 41-year-old woman with a large adenohypophyseal neoplasm presenting as a primary nonfunctioning tumor without pituitary insufficiency. Signs of mass effect with progressive unilateral ocular motility disorders and anterior pituitary failure developed rapidly. Histopathological examination of the trans-sphenoidally removed tumor showed a primary pituitary null cell tumor with high mitotic index. Pituitary carcinoma was suspected because of rapid relapse of ocular motility disorders and of intra-sellar tumor growth after surgery. Radiotherapy of the sellar and parasellar area with a total dose of 59.4 Gy was performed, achieving marked tumor reduction and a significant im...
This case report concerns a 31-year-old male with an aggressive pituitary tumor who presented initia...
Pituitary carcinoma is a rare malignancy and is difficult to manage. Pituitary carcinomas commonly p...
Background: Neuroendocrine tumors (NET) originate from the diffuse neuroendocrine system. These can ...
Introduction Pituitary carcinomas account for 0.1 or 0.2% of pituitary tumors. The authors report a ...
Abstract Background Pituitary carcinoma is very rare and hard to diagnose. However, some atypical pi...
Pituitary carcinoma is a extremely rare and is characterized by a very poor prognosis. Even if at d...
A 64-year-old woman experienced an episode of disorientation in relation to time, place, and people,...
<p><strong>Objective</strong> To introduce the experience of diagnosing and treating one case of pi...
NFMAs are benign tumors that do not produce any biologically active hormones and exceed 10 mm (0.39 ...
This case report concerns a 31-year-old male with an aggressive pituitary tumor who presented initia...
Criteria for the diagnosis of pituitary carcinoma are subject to controversy. Some authors do not ac...
Background As a kind of rare tumor, metastatic pituitary carcinoma is very difficult to diagnose cli...
Non-functioning pituitary neuroendocrine tumors do not cause endocrine symptoms related to hypersecr...
BACKGROUND: Pituitary carcinomas are rare and challenging clinical entities. Because of the paucity...
Abstract Background Pituitary carcinomas (PCs), defined as distant metastases of pituitary neoplasms...
This case report concerns a 31-year-old male with an aggressive pituitary tumor who presented initia...
Pituitary carcinoma is a rare malignancy and is difficult to manage. Pituitary carcinomas commonly p...
Background: Neuroendocrine tumors (NET) originate from the diffuse neuroendocrine system. These can ...
Introduction Pituitary carcinomas account for 0.1 or 0.2% of pituitary tumors. The authors report a ...
Abstract Background Pituitary carcinoma is very rare and hard to diagnose. However, some atypical pi...
Pituitary carcinoma is a extremely rare and is characterized by a very poor prognosis. Even if at d...
A 64-year-old woman experienced an episode of disorientation in relation to time, place, and people,...
<p><strong>Objective</strong> To introduce the experience of diagnosing and treating one case of pi...
NFMAs are benign tumors that do not produce any biologically active hormones and exceed 10 mm (0.39 ...
This case report concerns a 31-year-old male with an aggressive pituitary tumor who presented initia...
Criteria for the diagnosis of pituitary carcinoma are subject to controversy. Some authors do not ac...
Background As a kind of rare tumor, metastatic pituitary carcinoma is very difficult to diagnose cli...
Non-functioning pituitary neuroendocrine tumors do not cause endocrine symptoms related to hypersecr...
BACKGROUND: Pituitary carcinomas are rare and challenging clinical entities. Because of the paucity...
Abstract Background Pituitary carcinomas (PCs), defined as distant metastases of pituitary neoplasms...
This case report concerns a 31-year-old male with an aggressive pituitary tumor who presented initia...
Pituitary carcinoma is a rare malignancy and is difficult to manage. Pituitary carcinomas commonly p...
Background: Neuroendocrine tumors (NET) originate from the diffuse neuroendocrine system. These can ...